CNE1000055W8
CNE1000055W8
DIZAL PHARMACEUTICAL CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 27.89B EUR | 18.57B EUR | 25.21B EUR |
Enterprise Value | 27.5B EUR | 19.75B EUR | 26.43B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | 90.83x | -- | -- |
Price to Sales | 28.78x | 19.91x | 30.65x |
Price to Book | 24.68x | 16.44x | 20.42x |
EV/Revenue | 28.39x | 21.17x | 32.14x |
EV/EBITDA | -45.12x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -2.22% | -3.64% | -3.16% |